S
GWPH

swisspartners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

swisspartners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,000
Closed -$435K – 89
2021
Q1 		$435K Hold
2,000
– – 0.35% 58
2020
Q4 		$227K Buy
+2,000
New +$224K 0.2% 68

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

swisspartners's GWPH Position: Q2 2021 in Review

swisspartners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,000 shares — an estimated $435K sold.

swisspartners first reported a position in GWPH in Q4 2020 and held it in 2 quarters. The position peaked at $435K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • swisspartners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • swisspartners sold 2,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $435K.
  • swisspartners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2020 and held it in 2 quarters.
  • swisspartners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $435K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on swisspartners's 13F filing for Q2 2021, filed 11 Aug 2021.